ADIM
VAPO

Alpha DNA Investment Management’s Vapotherm, Inc. Common Stock VAPO Stock Holding History

Alpha DNA Investment Management’s Portfolio VAPO Stock Details VAPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed – – 706
2021
Q1 		$0 Hold
1
– – ﹤0.01% 800
2020
Q4 		$0 Buy
+1
New +$223 ﹤0.01% 634

Other funds holding VAPO

PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Alpha DNA Investment Management's VAPO Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Vapotherm, Inc. Common Stock (VAPO) in Q2 2021, closing a stake of 1 share.

Alpha DNA Investment Management first reported a position in VAPO in Q4 2020 and held it in 2 quarters. The position peaked at $0 in Q1 2021. 89 funds tracked by Wall St. Rank hold VAPO as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Vapotherm, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 1 Vapotherm, Inc. Common Stock share in Q2 2021.
  • Alpha DNA Investment Management first reported a position in Vapotherm, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Vapotherm, Inc. Common Stock position peaked at $0 in Q1 2021.
  • 89 funds tracked by Wall St. Rank held Vapotherm, Inc. Common Stock as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.